Ringel MD - Search Results

1

Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.

Bekaii-Saab T, Phelps MA, Li X, Saji M, Goff L, Kauh JS, O'Neil BH, Balsom S, Balint C, Liersemann R, Vasko VV, Bloomston M, Marsh W, Doyle LA, Ellison G, Grever M, Ringel MD, Villalona-Calero MA. Bekaii-Saab T, et al. Among authors: ringel md. J Clin Oncol. 2011 Jun 10;29(17):2357-63. doi: 10.1200/JCO.2010.33.9473. Epub 2011 Apr 25. J Clin Oncol. 2011. PMID: 21519026 Free PMC article. Clinical Trial.

2

Overexpression and overactivation of Akt in thyroid carcinoma.

Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M. Ringel MD, et al. Cancer Res. 2001 Aug 15;61(16):6105-11. Cancer Res. 2001. PMID: 11507060

3

Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice.

Bauer AJ, Terrell R, Doniparthi NK, Patel A, Tuttle RM, Saji M, Ringel MD, Francis GL. Bauer AJ, et al. Among authors: ringel md. Thyroid. 2002 Nov;12(11):953-61. doi: 10.1089/105072502320908286. Thyroid. 2002. PMID: 12490072

4

Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells.

Ramljak D, Coticchia CM, Nishanian TG, Saji M, Ringel MD, Conzen SD, Dickson RB. Ramljak D, et al. Among authors: ringel md. Exp Cell Res. 2003 Jul 15;287(2):397-410. doi: 10.1016/s0014-4827(03)00135-6. Exp Cell Res. 2003. PMID: 12837294

5

Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.

Vasko V, Saji M, Hardy E, Kruhlak M, Larin A, Savchenko V, Miyakawa M, Isozaki O, Murakami H, Tsushima T, Burman KD, De Micco C, Ringel MD. Vasko V, et al. Among authors: ringel md. J Med Genet. 2004 Mar;41(3):161-70. doi: 10.1136/jmg.2003.015339. J Med Genet. 2004. PMID: 14985374 Free PMC article.

6

BRAF T1796A transversion mutation in various thyroid neoplasms.

Xing M, Vasko V, Tallini G, Larin A, Wu G, Udelsman R, Ringel MD, Ladenson PW, Sidransky D. Xing M, et al. Among authors: ringel md. J Clin Endocrinol Metab. 2004 Mar;89(3):1365-8. doi: 10.1210/jc.2003-031488. J Clin Endocrinol Metab. 2004. PMID: 15001635

7

Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells.

Miyagi E, Braga-Basaria M, Hardy E, Vasko V, Burman KD, Jhiang S, Saji M, Ringel MD. Miyagi E, et al. Among authors: ringel md. Mol Carcinog. 2004 Oct;41(2):98-107. doi: 10.1002/mc.20042. Mol Carcinog. 2004. PMID: 15378648

8

Akt: a potential target for thyroid cancer therapy.

Kada F, Saji M, Ringel MD. Kada F, et al. Among authors: ringel md. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep;4(3):181-5. doi: 10.2174/1568008043339857. Curr Drug Targets Immune Endocr Metabol Disord. 2004. PMID: 15379721 Review.

9

Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.

Vasko VV, Gaudart J, Allasia C, Savchenko V, Di Cristofaro J, Saji M, Ringel MD, De Micco C. Vasko VV, et al. Among authors: ringel md. Eur J Endocrinol. 2004 Dec;151(6):779-86. doi: 10.1530/eje.0.1510779. Eur J Endocrinol. 2004. PMID: 15588246

10

Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.

Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C. Weber F, et al. Among authors: ringel md. J Clin Endocrinol Metab. 2005 May;90(5):2512-21. doi: 10.1210/jc.2004-2028. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15713710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page